DEFINE MASSIVE BLOOD LOSS. DEFINE MASSIVE BLOOD TRANSFUSION. ENUMERATE BLOOD CONSERVATION STRATEGIES DURING SURGERY

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

Why

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

I paid for credits

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

DEFINE MASSIVE BLOOD LOSS. DEFINE MASSIVE BLOOD TRANSFUSION. ENUMERATE BLOOD CONSERVATION STRATEGIES DURING SURGERY

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
I now have comprehensive information from multiple authoritative sources. Here is a detailed synthesis:

Massive Blood Loss, Massive Blood Transfusion & Blood Conservation Strategies


1. Definition of Massive Blood Loss

Massive blood loss is defined as:
  • Loss of the total blood volume (TBV) within 24 hours — approximately 10 units of packed red blood cells (pRBC) in a 70 kg adult (since a 70 kg adult has ~5 L total blood volume, roughly 7% of ideal body weight).
  • OR loss of 50% of total blood volume over a 3-hour period.
"Loss of total blood volume (10 units in a 70-kg adult) in 24 hr or loss of 50% of total blood volume over a 3-hr period." — Roberts and Hedges' Clinical Procedures in Emergency Medicine
In children, some centres use >40 mL/kg of anticipated blood product requirements as a defining threshold.

2. Definition of Massive Blood Transfusion (MBT)

Massive transfusion is the transfusion of:
  • ≥1 circulating patient blood volume within 24 hours (the most widely accepted definition), OR
  • ≥10 units of pRBCs within 24 hours in an average-sized adult.
"A common definition for massive transfusion is the transfusion of at least one circulating patient blood volume within 24 hours. An approximate alternative definition for an average-sized adult patient may be the transfusion of 10 or more pRBC units within 24 hours." — Tietz Textbook of Laboratory Medicine, 7e

Massive Transfusion Protocol (MTP)

Most institutions activate a MTP when massive transfusion is anticipated. A typical MTP pack contains:
  • 6 units pRBC + 6 units plasma + 1 apheresis platelet unit (reflecting a 1:1:1 ratio)
  • Some evidence supports a 1:1:2 strategy favoring pRBCs in specific populations
  • FFP/pRBC ratio of 1:1 may be most beneficial in exsanguinating hemorrhage
  • Cryoprecipitate is added if fibrinogen remains <1 g/dL after FFP
Physiologic consequences of massive transfusion include:
  • Dilutional coagulopathy (clotting factors fall to 25% activity after ~200% blood loss)
  • Dilutional thrombocytopenia
  • Hypocalcaemia (citrate toxicity)
  • Metabolic alkalosis
  • Hypothermia

3. Blood Conservation Strategies During Surgery

Blood conservation (now more broadly termed Patient Blood Management, PBM) involves a multimodal approach organised across three phases:

A. PREOPERATIVE STRATEGIES

StrategyDetails
Preoperative anaemia correctionIron supplementation (oral or IV) weeks before elective surgery; erythropoiesis-stimulating agents (ESAs/EPO) with iron for non-iron-deficiency anaemia or for patients refusing transfusion
Preoperative autologous donation (PAD)Patient donates their own blood 2–5 weeks before surgery; indicated for rare blood types, multiple antibodies, or those refusing allogenic blood; Hb must be >11 g/dL before each donation
Optimise anticoagulant/antiplatelet medicationsStop warfarin, novel anticoagulants, dual antiplatelet agents at appropriate pre-surgical intervals; use point-of-care testing to confirm residual effect
Identify high-risk patientsAdvanced age, preoperative anaemia, complex/redo surgery, emergency procedures, noncardiac comorbidities

B. INTRAOPERATIVE STRATEGIES

i. Acute Normovolemic Haemodilution (ANH)

  • Remove 1–2 units of whole blood from the patient before systemic heparinisation/surgery; replace with crystalloid/colloid
  • Blood is reinfused post-operatively, delivering fresh platelets and functional coagulation factors
  • Caution in: preoperative anaemia, severe aortic stenosis, high-grade left main coronary disease, haemodynamically unstable patients

ii. Intraoperative Blood Salvage (Cell Saver)

  • Shed blood is collected, washed, concentrated, and reinfused
  • Can yield haematocrit up to 70% per processed unit
  • Does not restore platelets or coagulation factors (washing removes them)
  • Absolute contraindications: admixture with topical haemostatic agents, sterile water, alcohol, hydrogen peroxide, or povidone-iodine
  • Use in malignancy/infection decided case-by-case

iii. Retrograde Autologous Priming (RAP) — Cardiac Surgery

  • Patient's blood displaces crystalloid prime from the cardiopulmonary bypass (CPB) circuit into an external reservoir
  • Reduces CPB-related haemodilution and extravascular lung water
  • Hypotension may occur; treat with vasoconstrictors or Trendelenburg positioning

iv. Antifibrinolytic Agents

  • Tranexamic acid (TXA): binds plasminogen, blocks fibrinogen lysis; reduces surgical bleeding and transfusion requirements without increased risk of PE, DVT, or MI
  • Epsilon-aminocaproic acid (EACA): similar mechanism; used in cardiac surgery with/without CPB
  • Aprotinin: was used but withdrawn after evidence of renal failure, MI, and death risk

v. Surgical Technique & Positioning

  • Meticulous surgical haemostasis
  • Optimal patient positioning to reduce venous engorgement (e.g., prone for spine surgery)
  • Induced hypotension where appropriate

vi. Minimally Invasive Extracorporeal Circulation (MiECC)

  • Shorter tubing and closed CPB circuits reduce priming volume and blood exposure, decreasing transfusion need in cardiac surgery

vii. Point-of-Care (POC) Coagulation Monitoring

  • Thromboelastography (TEG) or Rotational Thromboelastometry (ROTEM) to guide targeted blood component therapy
  • Avoids empirical, wasteful transfusions

C. TRANSFUSION THRESHOLD MANAGEMENT

  • Restrictive transfusion strategy: Transfuse pRBCs only when Hb <7 g/dL; maintain Hb 7–9 g/dL
  • In critically ill patients, restrictive strategy (Hb trigger <7 g/dL) is at least as beneficial as liberal strategy
  • Exception: Acute coronary ischaemia — slightly higher Hb target may be appropriate
  • Aim haematocrit ~30–35% to sustain haemostasis and oxygen delivery

D. PHARMACOLOGICAL ADJUNCTS

DrugIndication
Tranexamic acid / EACAAntifibrinolysis; reduces perioperative bleeding
DDAVP (desmopressin)Von Willebrand disease Type 1 & 2 (except 2B); uremic platelet dysfunction
Recombinant Factor VIIaLast resort when surgical control impossible, coagulopathy refractory to FFP/platelets/cryoprecipitate, and acidosis corrected
Prothrombin Complex Concentrates (PCC)Rapid reversal of vitamin K antagonists; 4-factor PCC preferred
Fibrinogen concentrate / CryoprecipitateWhen fibrinogen <1 g/dL despite FFP

Summary: Four Pillars of Patient Blood Management

(Miller's Anaesthesia / STS-SCA Guidelines 2021)
  1. Preoperative optimisation of RBC mass — treat anaemia before surgery
  2. Perioperative minimisation of RBC loss — optimise coagulation, use cell salvage
  3. Interdisciplinary blood conservation — multimodal, team-based approach
  4. Patient-centred decision-making — respect patient values (e.g., Jehovah's Witnesses)

Sources: Roberts and Hedges' Clinical Procedures in Emergency Medicine; Tietz Textbook of Laboratory Medicine 7e; Barash, Cullen & Stoelting's Clinical Anaesthesia 9e; Miller's Anaesthesia 10e

Jehovah's Witnesses)

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Here is a comprehensive, textbook-based overview of the management of Jehovah's Witnesses in the surgical/anaesthetic setting:

Jehovah's Witnesses and Blood Transfusion — Clinical Management


Who Are Jehovah's Witnesses?

Jehovah's Witnesses are a religious fellowship of over 7.8 million followers worldwide (~1.2 million in the United States alone). Their objection to blood transfusion is grounded in a literal interpretation of Biblical scripture:
  • Genesis 9:4 — "But you shall not eat flesh with its life, that is, its blood."
  • Leviticus 17:10 — "If any one of the house of Israel eats any blood, I will cut him off from among his people."
  • Acts 15:28–29 — "to keep abstaining from blood."
They believe that once blood leaves the body it should not be consumed or returned in any form, and that receiving a blood transfusion causes irreversible spiritual death — loss of eternal life. Since 1961, accepting a transfusion has been grounds for disfellowshipping (formal expulsion and shunning from the congregation). Most Jehovah's Witnesses knowingly accept the risk of physical death as a consequence of refusing blood.
"Receipt of a blood transfusion is believed to cause irreversible death to a member's soul without hope of eternal life. Most Jehovah's Witnesses understand and accept the threat of death as a possible result of refusing therapeutic transfusion." — Barash, Cullen & Stoelting's Clinical Anaesthesia, 9e

What Blood Products Do They Refuse?

Absolutely Refused (by devout members):

  • Whole blood
  • Packed red blood cells (pRBCs)
  • White blood cells (leucocytes)
  • Platelets
  • Plasma (including FFP)
  • Stored autologous blood (preoperative autologous donation)

"Grey Area" — Personal Decision (varies by individual):

  • Albumin — some accept
  • Immunoglobulins — some accept
  • Clotting factor concentrates (e.g., PCCs, Factor VIII/IX concentrates) — some accept
  • Erythropoietin (EPO — contains albumin in formulation) — some accept
  • Hemophiliac preparations — personal decision

Often Accepted (if blood remains in continuous circuit):

  • Crystalloids (normal saline, Hartmann's, etc.)
  • Colloids (hetastarch, dextran)
  • Acute normovolemic haemodilution (ANH) — accepted by some if blood remains in continuous contact with the circulatory system (not stored)
  • Intraoperative blood salvage (cell saver) — accepted by some if blood is in continuous circuit
  • Cardiopulmonary bypass (CPB) — accepted by some for same reason
"Techniques of acute normovolemic hemodilution and intraoperative blood salvage have been accepted by some Witnesses, however, as long as their blood maintains continuity with their circulatory systems at all times." — Morgan & Mikhail's Clinical Anaesthesiology, 7e

Medical & Anaesthetic Management Strategies

The goal is to maximise oxygen delivery and minimise blood loss without allogenic transfusion.

Preoperative Optimisation

StrategyDetail
Recombinant EPO (high-dose)Stimulates erythropoiesis to maximise preoperative Hb
IV iron supplementationCorrects iron-deficiency anaemia; maximises erythropoietic response
Vitamin B12 and folateSupplements to support red cell production
Stop antiplatelets/anticoagulantsOptimise coagulation before surgery
AntifibrinolyticsTranexamic acid (TXA), EACA — considered in planning
Prohemostatic agentsVitamin K, factor concentrates, desmopressin (DDAVP)

Intraoperative Strategies

StrategyDetail
ANHRemove blood just before surgery; keep in continuous circuit; reinfuse intraoperatively
Cell saver (IOBS)Salvage shed blood; acceptable to many Witnesses if circuit is unbroken
Controlled hypotensionReduce surgical field bleeding
Meticulous surgical haemostasisMinimise raw surface bleeding
Restricted blood drawsMinimise phlebotomy losses
POC coagulation monitoringTEG/ROTEM to guide targeted correction of coagulopathy

Management of Life-Threatening Anaemia (Hb <5 g/dL)

  • Optimise cardiac output (inotropes if needed)
  • Maximise oxygen delivery: 100% FiO₂, PEEP, ventilatory optimisation
  • Minimise oxygen consumption: sedation, hypothermia, muscle relaxation
  • Hyperbaric oxygen therapy: can dissolve sufficient O₂ to sustain life without haemoglobin; used in pulsed fashion (3–4 hr/day) to reduce oxygen debt until Hb recovers
  • Haemoglobin-based oxygen carriers (HBOCs): under investigation; not yet approved in the US but may revolutionise care for such patients
"Hyperbaric oxygen therapy can dissolve sufficient oxygen to sustain life in the absence of hemoglobin and may be another option when blood cannot be used." — Roberts & Hedges' Clinical Procedures in Emergency Medicine

Medicolegal Framework

Competent Adult

  • A competent adult has the absolute legal right to refuse blood transfusion — even if the decision is considered unwise or life-threatening.
  • They typically sign a waiver releasing medical practitioners from liability.
  • Courts have ruled: "The competent adult has the right to refuse a transfusion regardless of whether his refusal arises from fear, religious belief, recalcitrance, or cost."
  • However, this right is not absolute — courts may override refusal if it conflicts with state interests (preservation of life, prevention of suicide, protection of third parties).

Unconscious or Medically Incompetent Adult

  • If the patient's beliefs are unknown in an emergency → transfuse (implied consent under the emergency doctrine; family members cannot refuse on their behalf).
  • If beliefs are known in advance (e.g., patient carries a signed Jehovah's Witness card or advance directive) → courts tend to respect this objective evidence of patient intent.
  • Advance directives and signed cards are legally recognised expressions of autonomy.

Minors

  • Courts consistently override parental refusal of blood for children.
  • The state's interest in preserving the life of a minor takes precedence.
  • An urgent court order or temporary guardianship should be sought immediately.
  • In genuine emergencies, physicians are legally protected in transfusing a minor to save their life.

Practical Steps for Clinicians

  1. Engage early — for elective surgery, establish the patient's individual beliefs; do not assume all Witnesses hold the same position.
  2. Document thoroughly — record all discussions, patient capacity, decisions made, and consent/refusal.
  3. Contact the Hospital Ethics Committee and legal advisors if any uncertainty exists.
  4. Over 1,700 Hospital Liaison Committees exist worldwide through the Jehovah's Witnesses organisation — these can assist with personalised healthcare management plans.
  5. Seek an urgent court order for minors or unconscious patients without capacity.
"The best management for Jehovah's Witnesses is to have a well-prescribed perioperative care plan to maximise blood conservation strategies and a clear conversation about the patient's individual concerns and beliefs." — Barash, Cullen & Stoelting's Clinical Anaesthesia, 9e

Sources: Barash, Cullen & Stoelting's Clinical Anaesthesia 9e; Morgan & Mikhail's Clinical Anaesthesiology 7e; Roberts & Hedges' Clinical Procedures in Emergency Medicine; Rosen's Emergency Medicine

Brain death and apnoea test

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Excellent textbook content retrieved. Here is the complete, structured answer:

Brain Death and the Apnoea Test


Definition of Brain Death

Brain death is defined as the irreversible cessation of all brain and brainstem function, including the drive to breathe, in a patient with a known catastrophic neurological cause of coma.
"Brain death occurs when there is an absence of signs of brainstem function or motor response to deep central pain in the absence of pharmacologic or systemic medical conditions that could impair brain function." — Schwartz's Principles of Surgery, 11e
It is both medically and legally accepted as death in the United States and most countries worldwide. Importantly, brain death is a clinical determination — confirmatory tests are not mandatory if the full clinical examination (including a formal apnoea test) can be completed.
Most common causes:
  • Severe traumatic brain injury (TBI)
  • Aneurysmal subarachnoid haemorrhage (aSAH)
  • Massive intraparenchymal haemorrhage
  • Hypoxic-ischaemic brain injury (less common)

Prerequisites Before Brain Death Evaluation

All of the following confounders must be excluded before the examination is valid:
PrerequisiteRequirement
Cause of comaIrreversible; established by history and neuroimaging
TemperatureCore temperature ≥ 36°C (hypothermia excluded)
HaemodynamicsSystolic BP ≥ 100 mmHg
Sedatives/analgesicsNo residual effect
Neuromuscular blockersAbsent (use peripheral nerve stimulator if doubt)
Drug intoxication/poisoningExcluded (toxicology screen if indicated)
Acid-base/electrolytes/endocrineNo severe disturbances
No spontaneous respirationsConfirmed
"Brain death should not be determined within hours of emergency department evaluation or transfer from an outside facility" — Bradley & Daroff's Neurology, 7e

Clinical Examination — Brainstem Reflexes

All the following must be absent:

1. Pupillary Response

  • Pupils typically 4–7 mm (mid-dilated), non-reactive to bright light bilaterally
  • Constricted (pinpoint) pupils are NOT compatible with brain death — raise suspicion of opioid effect

2. Corneal Reflex

  • Absent bilaterally — tested with saline jet and tissue touch

3. Oculocephalic Reflex (Doll's Eye)

  • Tested only if C-spine integrity is ensured
  • Eyes remain fixed ("doll's eye" movement absent)

4. Oculovestibular Reflex (Ice-Water Calorics)

  • Head elevated to 30° (horizontal canal becomes vertical)
  • 50 mL ice water irrigated into each ear — observe for 1 minute, with 5 minutes between each side
  • In brain death: no eye movement
  • In comatose non-brain-dead patient: eyes deviate toward the cold side

5. Facial Response to Noxious Stimuli

  • No grimacing to: supraorbital notch pressure, temporomandibular joint compression

6. Gag Reflex

  • Absent — tested by stimulating posterior oropharynx (gloved finger)

7. Cough Reflex

  • Absent — suction catheter passed to carina, no cough (minimum 2 passes)

8. Motor Response to Deep Pain

  • No motor response to deep central pain: supraclavicular pinch, sternal rub, fingernail beds
  • Decerebrate or decorticate posturing not compatible with brain death
  • Spinal reflexes (e.g., triple flexion of lower limbs) — spinally mediated, compatible with brain death

Findings NOT Compatible with Brain Death (Box 6.2)

  • Nystagmus or spontaneous eye movements
  • Conjugate eye deviation
  • Pinpoint pupils
  • Grimacing to noxious stimulation
  • Decerebrate or decorticate posturing

The Apnoea Test

The apnoea test is performed last, after all brainstem reflexes are confirmed absent. It documents the absence of respiratory drive even when PaCO₂ rises to levels that would normally stimulate the respiratory centre.

Step-by-Step Protocol (Apnoeic Oxygenation-Diffusion Technique)

StepAction
1. Haemodynamic stabilitySBP ≥ 100 mmHg (vasopressors as needed)
2. NormocapniaAdjust ventilator → PaCO₂ 35–45 mmHg (baseline ABG)
3. Pre-oxygenation100% FiO₂ for 10 minutes → PaO₂ ≥ 200 mmHg
4. PEEP checkPatient maintains oxygenation on PEEP 5 cm H₂O; recruitment manoeuvre if needed
5. Disconnect ventilatorRemove from mechanical ventilation
6. Oxygenation maintenanceInsert insufflation catheter to carina at 6 L/min O₂, OR T-piece with CPAP valve at 10–20 cm H₂O
7. ObserveWatch for chest expansion, abdominal excursion, or gasping for 8–10 minutes
8. ABG at 8–10 minutesDraw arterial blood gas; reconnect to ventilator

Positive Apnoea Test (confirms brain death):

  • No respiratory effort, AND
  • PaCO₂ ≥ 60 mmHg, OR rise of ≥ 20 mmHg above normal baseline

Time of Death:

When the apnoea test is the final component of the examination, the time of death = time the arterial PCO₂ reached target in the absence of respiratory effort.

Aborting the Apnoea Test:

If the patient becomes haemodynamically unstable or desaturates during the test, abort and proceed to ancillary confirmatory tests.

Number of Examinations Required

Age GroupRequirement
Neonate (≥37 wks gestation) to 24 hours2 examinations, 2 separate days apart
30 days to 18 years2 examinations, 2 separate physicians, 12 hours apart
≥18 years (adults)1 examination sufficient (some US states require 2: AL, CA, FL, IA, KY, LA)
Alternative (adults)1 exam + 1 consistent confirmatory ancillary test

Confirmatory Ancillary Tests

Required when clinical exam cannot be fully completed (e.g., major facial trauma, inability to perform apnoea test due to haemodynamic instability):
TestFinding in Brain Death
Cerebral angiographyNo intracranial blood flow
Technetium radionuclide scanNo cerebral perfusion ("hollow skull" sign)
Transcranial Doppler (TCD)"To-and-fro" pattern — no net forward cerebral flow
EEGElectrocerebral silence (no potentials >2 mV over 30 minutes with ≥8 electrodes) — generally not favoured due to artefact
Auditory/Somatosensory Evoked PotentialsAbsent responses
"The clinical examination and the excluding of confounders remains the foundation of brain death determination." — Bradley & Daroff's Neurology in Clinical Practice, 7e

After Declaration of Brain Death

  • Family is informed that the patient has died but remains supported on artificial means
  • After adequate time, family is approached regarding organ donation
  • US federal law requires the physician to contact an organ procurement organization (OPO)
  • Members of the OPO approach the family separately from the medical team

Sources: Bradley & Daroff's Neurology in Clinical Practice 7e; Schwartz's Principles of Surgery 11e; Plum & Posner's Diagnosis and Treatment of Stupor and Coma

From anaesthesia and ICU books

Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Finding Sources
I now have comprehensive content from both Miller's Anesthesia and Barash's Clinical Anaesthesia. Here is the full answer drawn exclusively from these anaesthesia and ICU textbooks:

Brain Death and the Apnoea Test

From Anaesthesia & ICU Perspectives


Definition of Brain Death

"Brain death is declared when the clinical picture is consistent with irreversible cessation of all brain functions. Legal and medical brain death criteria differ from state to state, but all require permanent absence of both cerebral and brainstem functions." — Barash, Cullen & Stoelting's Clinical Anaesthesia, 9e
"The diagnosis of brain death remains one of the most challenging and controversial areas of neurocritical care. Physicians must have adequate training and understanding of the principles of brain death declaration and be able to apply them assiduously and without compromise." — Miller's Anesthesia, 10e
Brain death was originally codified by the Harvard criteria in 1968. The American Academy of Neurology (AAN) subsequently developed guidelines that are now widely adopted. It is important that the hospital has an institutionally approved protocol for brain death declaration and conduct of ancillary tests.

Prerequisites Before Brain Death Examination

All potentially reversible causes of coma must be excluded and corrected:
ConfounderRequirement
HypothermiaCore temperature ≥ 36°C
HypotensionSBP ≥ 100 mmHg
HypoglycaemiaCorrected
Drug/toxin intoxicationSedatives, analgesics, NMBAs excluded (toxicology screen if needed; peripheral nerve stimulator to confirm no residual NMB)
Acid-base/electrolyte/endocrine disturbancesCorrected
NeuroimagingClinical or imaging evidence of irreversible brain damage must be present
"Potential reversible causes of coma such as hypothermia, hypotension, hypoglycemia, drug or toxin intoxications, and acid-base or electrolyte imbalances must be corrected prior to declaration of brain death." — Barash, Cullen & Stoelting's Clinical Anaesthesia, 9e

Clinical Examination — Brainstem Reflexes

Brain-dead donors are:
  • Unresponsive to all sensory stimuli
  • Have no brainstem reflexes
  • Have no ventilatory drive (confirmed by apnoea testing)
  • May have complex motor activity originating from the spinal cord or peripheral nerves — this does NOT exclude brain death

The following must ALL be absent:

ReflexMethod
Pupillary light reflexAbsent bilaterally; pupils typically mid-dilated (4–7 mm)
Corneal reflexAbsent bilaterally
Oculocephalic (Doll's Eyes)Only if C-spine integrity confirmed; absent
Oculovestibular (Ice-water calorics)50 mL ice water each ear — no eye movement
Facial response to painNo grimacing to supraorbital or TMJ pressure
Gag reflexAbsent to posterior pharyngeal stimulation
Cough reflexAbsent to deep tracheal suctioning (to carina, ≥2 passes)
Motor responseNo response to deep central pain in all 4 limbs

The Apnoea Test

The apnoea test is the final and most critical component of the brain death examination. It confirms the irreversible absence of respiratory drive — i.e., no breathing effort even when PaCO₂ rises to a level that would normally maximally stimulate medullary respiratory centres.
"One of the tests should include an appropriately conducted apnea trial in the presence of the responsible physician, with confirmation of adequate changes in PaCO₂." — Miller's Anesthesia, 10e

Step-by-Step Protocol

StepAction
1.Confirm haemodynamic stability: SBP ≥ 100 mmHg (titrate vasopressors as needed)
2.Adjust ventilator to achieve normocapnia: PaCO₂ 35–45 mmHg (baseline ABG)
3.Pre-oxygenate with 100% O₂ for 10 minutes → PaO₂ ≥ 200 mmHg
4.Confirm PEEP 5 cm H₂O maintains oxygenation (recruitment manoeuvre if needed)
5.Disconnect ventilator
6.Deliver O₂ via insufflation catheter to carina at 6 L/min, OR T-piece with CPAP valve at 10–20 cm H₂O
7.Observe for 8–10 minutes for any chest/abdominal movement or gasping
8.Draw ABG at 8–10 minutes, then reconnect ventilator

Positive Test (confirms brain death):

  • No respiratory efforts, AND
  • PaCO₂ ≥ 60 mmHg, OR ≥ 20 mmHg rise from normal baseline

Aborting the Test:

If haemodynamic instability or significant desaturation develops → abort and proceed to ancillary confirmatory test
"Four-vessel CBF angiograms are the 'gold standard' and are usually required to diagnose brain death during barbiturate coma or if a confirmatory apnea test cannot be performed." — Miller's Anesthesia, 10e

Confirmatory Ancillary Tests

Required when clinical examination is incomplete or apnoea test cannot be safely performed:
TestFinding in Brain Death
Cerebral 4-vessel angiographyNo intracranial blood flow ("gold standard")
Technetium radionuclide scanNo cerebral perfusion
Transcranial Doppler (TCD)"To-and-fro" flow pattern — no net forward cerebral flow
EEGElectrocerebral silence (not favoured — artefact-prone)
Auditory / Somatosensory Evoked PotentialsAbsent
"If the clinical criteria are incomplete, then ancillary testing such as cerebral angiography, transcranial Doppler, and/or electroencephalography can be obtained to confirm the clinical examination." — Barash, Cullen & Stoelting's Clinical Anaesthesia, 9e
Important: Physicians involved in the transplant recipient process should NOT be involved in the declaration of brain death of a donor.

Pathophysiological Changes After Brain Death (ICU Perspective)

Brain death triggers two distinct haemodynamic phases with widespread systemic effects:

Phase 1 — Catecholamine Storm (Sympathetic Surge)

  • Intense vasoconstriction → hypertensive crisis (80–90%)
  • Tachycardia
  • Redistribution of blood volume → visceral ischaemia
  • Acute myocardial injury — echocardiographic dysfunction seen in 40% of potential heart donors

Phase 2 — Autonomic Collapse (Brainstem Death / Herniation)

  • Loss of sympathetic tone → vasodilation, vasoplegia
  • Profound hypotension (80–90%)
  • Reduced cardiac output
  • Hypovolemia (capillary leakage, osmotherapy for ICP, diabetes insipidus)

Table: Pathophysiologic Changes with Brain Death (Miller's Anesthesia 10e)

Signs/SymptomsMechanismIncidence
HypertensionCatecholamine storm80–90%
HypotensionVasoplegia, hypovolemia, myocardial dysfunction80–90%
Bradycardia / arrhythmiasCatecholamine storm, myocardial damage25–30%
Pulmonary oedemaBlood volume shift, capillary damage10–20%
Diabetes insipidus (DI)Posterior pituitary damage45–90%
DICTissue thromboplastin release from brain tissue30–55%
HypothermiaHypothalamic damage, ↓ metabolic rate, vasodilationVariable
Hyperglycaemia↓ insulin, ↑ insulin resistanceCommon

Endocrine Disturbances:

  • Central DI (loss of posterior pituitary) → severe fluid and electrolyte derangements (up to 90%)
  • Anterior pituitary failure → ↓ T3, T4, ACTH, TSH, GH
  • Hypothalamic dysfunction → loss of temperature regulation (hypothermia follows initial hyperthermia)

Respiratory:

  • ↑ SVR → blood shifts to pulmonary circulation → pulmonary capillary leakage → neurogenic pulmonary oedema
  • Proinflammatory cytokine release at alveoli → early graft failure risk in lung donors
  • Without ventilatory support → apnoea → cardiac arrest

ICU Management of the Brain-Dead Organ Donor (Barash's Clinical Anaesthesia 9e)

GoalTarget
MAP> 60 mmHg
Urine output≥ 1 mL/kg/h
LV ejection fraction≥ 45%
Serum sodium< 155 mmol/L (higher levels impair liver graft function)
CVP6–12 mmHg
Arterial PCO₂30–35 mmHg
Vasopressors:
  • Dopamine — traditional first-line
  • Vasopressin — preferred alternative; reduces pressor requirements, protects lung function, improves organ procurement rates
  • Norepinephrine/phenylephrine — reserved for severe shock (high-dose catecholamines are detrimental to organs)
Hormone Replacement:
  • Vasopressin/DDAVP — for DI and haemodynamic stabilisation
  • T3 (triiodothyronine) — 4 µg IV bolus then 3 µg/hr infusion; recommended for cardiac donors with EF <45%
  • Methylprednisolone — reduces systemic inflammatory response
Ventilation:
  • Lung-protective strategy: tidal volume 6–8 mL/kg, PEEP adjusted to minimise FiO₂
  • For lung donors: maintain low CVP (diuretics before lung procurement)
  • For kidney donors: higher filling pressures preferred
Neuromuscular Blockade:
  • Brain-dead patients may have intact spinal reflexes → NMB required during organ procurement to prevent movement

Sources: Miller's Anesthesia 10e; Barash, Cullen & Stoelting's Clinical Anaesthesia 9e
This is a shared conversation. Sign in to Orris to start your own chat.